Search This Blog

Wednesday, June 26, 2019

Anthem on board with Teleflex UroLift device

Anthem, one of the leading health insurance providers is now coveringTeleflex’s (NYSE:TFX) UroLift System, a minimally invasive treatment for men with benign prostatic hyperplasia (BPH).
With the announcement of this new coverage, all independent licensees of the Blue Cross Blue Shield Association now allow members access to the UroLift System treatment for enlarged prostate.
UroLift is a device that is placed in the urethra to hold the prostate lobes apart to improve urine flow.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.